Telix Pharmaceuticals wins FDA approval for PIXCLARA glioma imaging
FDA approves Telix Pharmaceuticals’ PIXCLARA, the first FET-PET drug for differentiating glioma progression from treatment-related change.
Medical Devices & Diagnostics